{"title":"[前列腺癌:诊断影像学现状]。","authors":"B N Bloch, T Helbich, Gertraud Heinz-Peer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate carcinoma showed a strong increase in industrial countries and today it is the second common cause of cancer related death. Prostate specific antigen allows early detection of prostate cancer, US-guided biopsy is employed for proof of diagnosis. The role of imaging has been discussed very contrarily. However, different options for treatment of prostate cancer and last but not least technological advances of different imaging modalities seem to reassess the role of imaging in prostate cancer.</p>","PeriodicalId":76823,"journal":{"name":"Wiener medizinische Wochenschrift. Supplement","volume":" 113","pages":"89-91"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Prostatic carcinoma: current status of diagnostic imaging].\",\"authors\":\"B N Bloch, T Helbich, Gertraud Heinz-Peer\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Prostate carcinoma showed a strong increase in industrial countries and today it is the second common cause of cancer related death. Prostate specific antigen allows early detection of prostate cancer, US-guided biopsy is employed for proof of diagnosis. The role of imaging has been discussed very contrarily. However, different options for treatment of prostate cancer and last but not least technological advances of different imaging modalities seem to reassess the role of imaging in prostate cancer.</p>\",\"PeriodicalId\":76823,\"journal\":{\"name\":\"Wiener medizinische Wochenschrift. Supplement\",\"volume\":\" 113\",\"pages\":\"89-91\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Wiener medizinische Wochenschrift. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiener medizinische Wochenschrift. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Prostatic carcinoma: current status of diagnostic imaging].
Prostate carcinoma showed a strong increase in industrial countries and today it is the second common cause of cancer related death. Prostate specific antigen allows early detection of prostate cancer, US-guided biopsy is employed for proof of diagnosis. The role of imaging has been discussed very contrarily. However, different options for treatment of prostate cancer and last but not least technological advances of different imaging modalities seem to reassess the role of imaging in prostate cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
